Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

3D Facial Scanning in Full-Arch Implant Prosthodontics: Time Efficiency and Patient Satisfaction

5 août 2026 mis à jour par: Lamiaa Farouk, Ain Shams University

Effect of Integrating 3D Facial Scanning in Full-Arch Implant Prosthetics: Time Efficiency and Patient Satisfaction

This study compares two ways of planning the bite (jaw-relation) stage of full-arch, implant-supported dental prosthesis treatment: a standard digital approach, and the same approach with the addition of 3D facial scanning, which lets the dental team plan the new teeth against a scan of the patient's own face. The study measured how patients felt about their treatment using a validated questionnaire, and also tracked how many clinic visits and adjustments each approach needed. Twenty-two patients took part, randomly assigned to one of the two approaches.

Aperçu de l'étude

Description détaillée

Full-arch implant-supported prosthetic rehabilitation requires accurate jaw-relation recording, which determines both the functional relationship between the arches and the esthetic integration of the final prosthesis within the patient's face. Conventional digital workflows rely on intraoral scanning and wax-rim jaw-relation techniques without reference to extraoral facial anatomy. This prospective, randomized, single-center pilot trial compared a conventional-digital hybrid workflow (Group A) with an enhanced digital workflow incorporating 3D facial scanning (Group B) in patients undergoing full-arch, implant-supported maxillary prosthetic rehabilitation (All-on-6 configuration). All patients received six implants placed using a fully guided surgical protocol with a stackable surgical guide, followed by an immediately loaded PMMA provisional prosthesis during a three-month osseointegration period. Following healing, patients were randomly allocated (computer-generated sequence, allocation concealed by an independent third party) to Group A or Group B for the prosthetic (jaw-relation recording) phase. In Group B, 3D facial scanning was merged with intraoral scans and CBCT data to guide prosthetic design against facial reference planes. The primary outcome was patient-reported oral health-related quality of life, measured using the validated short-form Oral Health Impact Profile (OHIP-14) questionnaire, administered after four weeks of intraoral trial wear of the try-in prosthesis (T1) and again four weeks after delivery of the definitive prosthesis (T2). Secondary outcomes included the number of clinical appointments and chairside adjustments required to complete the prosthetic phase, and implant/prosthesis survival at six months. The definitive prosthesis in both groups consisted of a milled cobalt-chromium framework with layered zirconia, with a mutually protected occlusal scheme. Outcome assessment (clinical/technical evaluation and statistical analysis) was blinded; blinding of patients and the treating clinician was not feasible given the visibly different nature of the two workflows.

Type d'étude

Interventionnel

Inscription (Réel)

22

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Cairo, Egypte
        • Oral and Maxillofacial Prosthodontics Department, Faculty of Dentistry, Ain Shams University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Adults (≥18 years) indicated for full-arch maxillary implant-supported fixed prosthetic rehabilitation
  • Completion of the surgical phase with stable implant osseointegration
  • Presence of healthy peri-implant soft tissues
  • Adequate oral hygiene status
  • Sufficient bone and soft-tissue conditions compatible with full-arch prosthetic rehabilitation
  • Ability to comply with all scheduled follow-up visits
  • Capacity to maintain natural head position during facial scanning procedures
  • Absence of significant gag reflex interfering with scanning/impression procedures
  • Ability to communicate effectively and complete questionnaires
  • Provision of written informed consent
  • Physically and psychologically fit for the planned treatment

Exclusion Criteria:

  • Severe skeletal or orthognathic discrepancies
  • History of significant facial trauma or surgery affecting facial symmetry
  • Prior maxillofacial pathology affecting the surgical/prosthetic site
  • Uncontrolled systemic diseases affecting healing or treatment tolerance
  • Use of medications that alter osseointegration or facial soft tissues
  • Active oral or peri-implant infection
  • Neuromuscular disorders or temporomandibular joint dysfunction affecting jaw positioning
  • Conditions affecting the ability to maintain stable head position for scanning
  • Severe psychomotor limitations
  • Known hypersensitivity to materials used in bite registration or prosthesis fabrication
  • Inability or unwillingness to provide informed consent
  • Pregnancy or lactation, if deemed a contraindication by the supervising clinician
  • Poor compliance or demonstrated unreliability in past dental or medical care

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Conventional-Digital Hybrid Workflow
aw-relation recording using intraoral digital scanning, digitally fabricated bite blocks, and a traditional wax-rim jaw-relation technique with facebow transfer and mechanical articulator mounting, without facial scanning.
Jaw-relation recording using intraoral digital scanning, digitally fabricated bite blocks, and a traditional wax-rim jaw-relation technique with facebow transfer and mechanical articulator mounting, w
Expérimental: Enhanced Digital Workflow with 3D Facial Scanning
Same base digital workflow as Group A, with the addition of high-resolution 3D facial scanning (Shining 3D structured-light scanner), merged with intraoral scans and CBCT data via Exocad software to guide prosthetic alignment against extraoral facial landmarks.
Integration of 3D facial scanning into the jaw-relation recording stage of full-arch implant prosthetic rehabilitation, merging facial, intraoral, and CBCT datasets to guide prosthetic design against facial reference planes. Performed in addition to the same base digital workflow described in Intervention 1.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Total Oral Health Impact Profile-14 (OHIP-14) Score at Trial-Wear Timepoint
Délai: 4 weeks
Patient-reported oral health-related quality of life, 14 items across 7 domains, scored 0-56 (higher = worse). Assessed after the patient had worn the try-in (trial) prosthesis intraorally for four weeks (T1).
4 weeks
Total Oral Health Impact Profile-14 (OHIP-14) Score at Post-Delivery Timepoint
Délai: 4 weeks
Patient-reported oral health-related quality of life, 14 items across 7 domains, scored 0-56 (higher = worse). Assessed four weeks after delivery of the definitive prosthesis (T2).
4 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Number of Clinical Appointments to Complete the Prosthetic Phase
Délai: up to 12 weeks
Total number of clinic visits from jaw-relation registration through prosthesis delivery.
up to 12 weeks
Number of Try-In Adjustments
Délai: up to 8 weeks
Number of chairside occlusal corrections (selective grinding, material addition, or jaw-relation re-verification) required at try-in before definitive fabrication.
up to 8 weeks
Implant and Prosthesis Survival / Complications at 6 Months
Délai: 6 months post-delivery
Clinical review for implant failure, prosthesis fracture, or other mechanical/biological complications.
6 months post-delivery

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

31 octobre 2024

Achèvement primaire (Réel)

1 septembre 2025

Achèvement de l'étude (Réel)

25 juillet 2026

Dates d'inscription aux études

Première soumission

1 août 2026

Première soumission répondant aux critères de contrôle qualité

5 août 2026

Première publication (Réel)

7 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

7 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared. The original informed consent obtained from participants covered their participation in this study but did not include provisions for the public sharing of individual-level, de-identified data with third parties or external researchers. In addition, given the small sample size (n = 11 per group) within a single department, there is a meaningful risk that even de-identified individual-level data could be re-identified. No data-sharing repository or access infrastructure has been established for this dataset. Aggregate, de-identified results are reported in the published thesis and any resulting publications.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner